Horizon Pharma PLC HZNP shares are trading lower by $4.73 (30 percent) at $10.85 in Monday's session.
The catalyst for the decline is a Q1 EPS miss of $0.02 along with sales miss of $27 million. The company also lowered FY 2017 guidance for sales to $1.00-$1.04 billion from $1.24-$1.29 billion.
After a lower open, Horizon's stock had a brief $0.02 pop to $11.17 before continuing its move lower.
The ensuing decline found support ahead of its October 2014 low ($10.15) at $10.35 and has mounted a nice rebound that has yet to reach the $11.00 handle, with the high of the bounce being $10.93 as of 10:50 a.m. EST.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
